INS and polycystic ovary syndrome: In comparison, GLP-1 receptor agonists such as exenatide and liraglutide result in modest weight loss women with PCOS by reducing inflammatory cytokines and improve sex hormone abnormalities, insulin sensitivity, and the menstrual cycle to even greater extent than metformin [184].